Nana

Supply Chain Paralysis: Boston Scientific Cyberattack Highlights Escalating Medtech Vulnerabilities

• Treatment Innovations

Supply Chain Paralysis: Boston Scientific Cyberattack Highlights Escalating Medtech Vulnerabilities

Nana August 28, 2026

In a development that has sent ripples of concern through the global healthcare infrastructure, Boston Scientific—a titan...

Read More Read more about Supply Chain Paralysis: Boston Scientific Cyberattack Highlights Escalating Medtech Vulnerabilities

Decoding the Genome: How Interchromosomal Insertions Drive Neurological Disease

• Genomics and Precision Medicine

Decoding the Genome: How Interchromosomal Insertions Drive Neurological Disease

Nana August 28, 2026

In the rapidly evolving field of human genetics, the "dark matter" of our genome—the vast, non-coding regions...

Read More Read more about Decoding the Genome: How Interchromosomal Insertions Drive Neurological Disease

Unveiling the Invisible: New Imaging Breakthrough FINICI Revolutionizes Enzyme Mapping

• Chemotherapy and Targeted Therapy

Unveiling the Invisible: New Imaging Breakthrough FINICI Revolutionizes Enzyme Mapping

Nana August 28, 2026

For decades, the field of cellular biology has been haunted by a fundamental limitation in optical physics....

Read More Read more about Unveiling the Invisible: New Imaging Breakthrough FINICI Revolutionizes Enzyme Mapping

Beyond the Needle: Micron Biomedical’s $4.5M Breakthrough in Radiation Countermeasures

• Chemotherapy and Targeted Therapy

Beyond the Needle: Micron Biomedical’s $4.5M Breakthrough in Radiation Countermeasures

Nana August 27, 2026

In a significant leap forward for emergency medical response, Micron Biomedical has secured a $4.5 million contract...

Read More Read more about Beyond the Needle: Micron Biomedical’s $4.5M Breakthrough in Radiation Countermeasures

Market Volatility Hits Spyre Therapeutics Following Mixed Results for Lead TL1A Candidate

• Treatment Innovations

Market Volatility Hits Spyre Therapeutics Following Mixed Results for Lead TL1A Candidate

Nana August 27, 2026

By Delilah Alvarado Published August 26, 2026 The biotechnology sector witnessed a significant correction in market sentiment...

Read More Read more about Market Volatility Hits Spyre Therapeutics Following Mixed Results for Lead TL1A Candidate

Decoding Destiny: Could Newborn Genomic Screening Revolutionize Childhood Cancer Prevention?

• Clinical Oncology Education

Decoding Destiny: Could Newborn Genomic Screening Revolutionize Childhood Cancer Prevention?

Nana August 26, 2026

In the quiet hours following a baby’s birth, the standard "heel-prick" test has long served as a...

Read More Read more about Decoding Destiny: Could Newborn Genomic Screening Revolutionize Childhood Cancer Prevention?

Patent Battle Escalates: Guardant Health Faces $245M Judgment in Landmark DNA Sequencing Dispute

• Treatment Innovations

Patent Battle Escalates: Guardant Health Faces $245M Judgment in Landmark DNA Sequencing Dispute

Nana August 25, 2026

In a significant legal development that has sent ripples through the genomic diagnostics industry, a US federal...

Read More Read more about Patent Battle Escalates: Guardant Health Faces $245M Judgment in Landmark DNA Sequencing Dispute

Roche Secures FDA Clearance for Elecsys pTau217: A New Frontier in Alzheimer’s Diagnostics

• Treatment Innovations

Roche Secures FDA Clearance for Elecsys pTau217: A New Frontier in Alzheimer’s Diagnostics

Nana August 25, 2026

In a landmark development for neurodegenerative medicine, Roche has announced that its Elecsys pTau217 blood test has...

Read More Read more about Roche Secures FDA Clearance for Elecsys pTau217: A New Frontier in Alzheimer’s Diagnostics

Cellares Shifts Strategy: Biotech Startup Cuts 100 Jobs Following Major Contract Termination

• Treatment Innovations

Cellares Shifts Strategy: Biotech Startup Cuts 100 Jobs Following Major Contract Termination

Nana August 25, 2026

By Gwendolyn Wu | Updated August 24, 2026 In a sudden reversal of fortune for one of...

Read More Read more about Cellares Shifts Strategy: Biotech Startup Cuts 100 Jobs Following Major Contract Termination

Navigating the Storm: Guiding Children Through Parental Cancer Recurrence

• Patient Advocacy and Support

Navigating the Storm: Guiding Children Through Parental Cancer Recurrence

Nana August 24, 2026

Introduction: The Unfolding Challenge The initial diagnosis of cancer in a parent is a seismic event for...

Read More Read more about Navigating the Storm: Guiding Children Through Parental Cancer Recurrence